Figure 2.
Best percentage change in tumor size from baseline with prexasertib 80 mg/m2 and prexasertib 105 mg/m2. Subjects with both baseline and post‐baseline values are included. Tumor types: a, small intestine carcinoma; b, rhabdomyosarcoma; c, malignant neoplasm of thymus; d, liposarcoma; e, squamous cell carcinoma of unknown origin; f, skin cancer; g, squamous cell carcinoma of lung; h, esophageal squamous cell carcinoma; i, endometrial adenocarcinoma; j, transitional cell carcinoma. PD, progressive disease; SD, stable disease